Lack of an effect of a novel ß₃-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study

dc.contributor.authorRedman, Leanne Mareeen
dc.contributor.authorde Jonge, Lilianen
dc.contributor.authorFang, Xiaobingen
dc.contributor.authorGamlin, B.en
dc.contributor.authorRecker, D.en
dc.contributor.authorGreenway, F. L.en
dc.contributor.authorSmith, Steven R.en
dc.contributor.authorRavussin, Ericen
dc.contributor.schoolSchool of Paediatrics and Reproductive Health : Obstetrics and Gynaecologyen
dc.date.issued2007en
dc.description.statementofresponsibilityLeanne M. Redman, Lilian de Jonge, Xiaobing Fang, Betsy Gamlin, David Recker, Frank L. Greenway, Steven R. Smith and Eric Ravussinen
dc.identifier.citationJournal of Clinical Endocrinology and Metabolism, 2007; 92 (2):527-531en
dc.identifier.doi10.1210/jc.2006-1740en
dc.identifier.issn0021-972Xen
dc.identifier.urihttp://hdl.handle.net/2440/45590
dc.language.isoenen
dc.publisherEndocrine Societyen
dc.rightsCopyright © 2007 by The Endocrine Societyen
dc.titleLack of an effect of a novel ß₃-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized studyen
dc.title.alternativeLack of an effect of a novel beta(3)-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized studyen
dc.typeJournal articleen

Files